Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: Updated time-to-events results and prognostic factors for time to progression

1. Mateos, M.-V.
2. Hernández, J.M.
3. Hernández, M.T.
4. Gutiérrez, N.C.
5. Palomera, L.
6. Fuertes, M.
7. Garcia-Sanchez, P.
8. Lahuerta, J.J.
9. De La Rubia, J.
10. Terol, M.-J.
11. Sureda, A.
12. Bargay, J.
13. Ribas, P.
14. Alegre, A.
15. De Arriba, F.
16. Oriol, A.
17. Carrera, D.
18. García-Laraña, J.
19. García-Sanz, R.
20. Bladé, J.
21. Prósper, F.
22. Mateo, G.
23. Esseltine, D.-L.
24. Van De Velde, H.
25. San Miguel, J.F.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.3324/HAEMATOL.12106 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

•